ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2022; 12(8):3607. doi:10.7150/thno.73098 This issue Cite
Erratum
Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum
Feng Zhang1,3,4, Shuai Lu5, Jianlin He2, Huanhuan Jin1, Feixia Wang1, Li Wu1,3,4, Jiangjuan Shao3,4, Anping Chen6, Shizhong Zheng1,3,4 
1. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
2. Third Institute of Oceanography, State Oceanic Administration, Xiamen 361005, China.
3. Jiangsu Key Laboratory of Therapeutic Material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
4. State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
5. School of Science, China Pharmaceutical University, Nanjing 211198, China.
6. Department of Pathology, School of Medicine, Saint Louis University, MO 63104, USA.
Citation:
Zhang F, Lu S, He J, Jin H, Wang F, Wu L, Shao J, Chen A, Zheng S. Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum. Theranostics 2022; 12(8):3607. doi:10.7150/thno.73098. https://www.thno.org/v12p3607.htm
Other stylesCorrected-article in Theranostics, Volume 8, 610
The authors regret that the original version of this paper unfortunately contained an inappropriate representative image of Boyden chamber assay. An inappropriate image was inadvertently used for the HSC-LX2 Ligu+GW9662 (Figure 4F) during the assembly of this figure. The authors confirm that the correction of Figure 4F does not affect the original conclusions. The authors sincerely apologize for any inconvenience or misunderstanding that the error may have caused. The corrected image is shown below.
Figure 1
Corrected image for original Figure 4F.
Author contact
Corresponding author: Dr Shizhong Zheng, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, Jiangsu, China. Tel: 86-025-85811246; Email: 300631edu.cn, nytwscom
Published 2022-4-26
Citation styles
APA
Zhang, F., Lu, S., He, J., Jin, H., Wang, F., Wu, L., Shao, J., Chen, A., Zheng, S. (2022). Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum. Theranostics, 12(8), 3607. https://doi.org/10.7150/thno.73098.
ACS
Zhang, F.; Lu, S.; He, J.; Jin, H.; Wang, F.; Wu, L.; Shao, J.; Chen, A.; Zheng, S. Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum. Theranostics 2022, 12 (8), 3607. DOI: 10.7150/thno.73098.
NLM
Zhang F, Lu S, He J, Jin H, Wang F, Wu L, Shao J, Chen A, Zheng S. Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum. Theranostics 2022; 12(8):3607. doi:10.7150/thno.73098. https://www.thno.org/v12p3607.htm
CSE
Zhang F, Lu S, He J, Jin H, Wang F, Wu L, Shao J, Chen A, Zheng S. 2022. Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum. Theranostics. 12(8):3607.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.